sulphasalazine ( sasp ) is now accepted as an effective slow-acting antirheumatic drug for treating active rheumatoid arthritis ( ra ) , but has not been previously evaluated in psoriatic arthritis .
C0036078
sulphasalazine
C0003873
rheumatoid arthritis